Insider Trading
Schrodinger Insider Sold Shares Worth $927,970, According to a Recent SEC Filing
Karen Akinsanya, President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships, on September 17, 2026, sold 31,599 shares in Schrodinger (SDGR) for $927,970. Following the Form 4 filing with the SEC, Akinsanya has control over a total of 69,956 common shares of the company, with 69,956 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1490978/000179767226000006/xslF345X05/wk-form4_1790025313.xml
$SDGR
